NovaBay Pharmaceuticals to Hold Third Quarter 2016 Conference Call on November 10

EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova® lid and lash hygiene product for the domestic eye care market, announces that it will report third quarter 2016 financial results after market close on Thursday, November 10. Management will hold an investment community conference call that day to discuss financial results and provide a Company update.             DATE: Thursday,